These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 24105991)
1. Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma. Okamoto T; Mandai M; Matsumura N; Yamaguchi K; Kondoh H; Amano Y; Baba T; Hamanishi J; Abiko K; Kosaka K; Murphy SK; Mori S; Konishi I Mol Carcinog; 2015 Jan; 54(1):35-49. PubMed ID: 24105991 [TBL] [Abstract][Full Text] [Related]
2. Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival. Amano Y; Mandai M; Yamaguchi K; Matsumura N; Kharma B; Baba T; Abiko K; Hamanishi J; Yoshioka Y; Konishi I Oncotarget; 2015 Sep; 6(28):26002-17. PubMed ID: 26318292 [TBL] [Abstract][Full Text] [Related]
3. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes. Yamaguchi K; Mandai M; Oura T; Matsumura N; Hamanishi J; Baba T; Matsui S; Murphy SK; Konishi I Oncogene; 2010 Mar; 29(12):1741-52. PubMed ID: 20062075 [TBL] [Abstract][Full Text] [Related]
4. Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction. Mandai M; Amano Y; Yamaguchi K; Matsumura N; Baba T; Konishi I Oncotarget; 2015 Oct; 6(31):30704-14. PubMed ID: 26375553 [TBL] [Abstract][Full Text] [Related]
5. Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells. Kao YC; Lin MC; Lin WC; Jeng YM; Mao TL Histopathology; 2012 Nov; 61(5):760-8. PubMed ID: 22747504 [TBL] [Abstract][Full Text] [Related]
6. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma. Huang W; Cheng X; Ji J; Zhang J; Li Q Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression. Suzuki E; Kajita S; Takahashi H; Matsumoto T; Tsuruta T; Saegusa M Lab Invest; 2015 Aug; 95(8):962-72. PubMed ID: 26030369 [TBL] [Abstract][Full Text] [Related]
8. HNF-1β in ovarian carcinomas with serous and clear cell change. DeLair D; Han G; Irving JA; Leung S; Ewanowich CA; Longacre TA; Gilks CB; Soslow RA Int J Gynecol Pathol; 2013 Nov; 32(6):541-6. PubMed ID: 24071869 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression. Kato N; Motoyama T Histopathology; 2008 May; 52(6):682-8. PubMed ID: 18393978 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor. Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020 [TBL] [Abstract][Full Text] [Related]
11. Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma. Kato N; Toukairin M; Asanuma I; Motoyama T Diagn Cytopathol; 2007 Apr; 35(4):193-7. PubMed ID: 17351940 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of cell death and induction of G2 arrest accumulation in human ovarian clear cells by HNF-1β transcription factor: chemosensitivity is regulated by checkpoint kinase CHK1. Shigetomi H; Sudo T; Shimada K; Uekuri C; Tsuji Y; Kanayama S; Naruse K; Yamada Y; Konishi N; Kobayashi H Int J Gynecol Cancer; 2014 Jun; 24(5):838-43. PubMed ID: 24804869 [TBL] [Abstract][Full Text] [Related]
13. Clear cell carcinoma of the ovary: potential pathogenic mechanisms (Review). Kajihara H; Yamada Y; Kanayama S; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sado T; Oi H; Kobayashi H Oncol Rep; 2010 May; 23(5):1193-203. PubMed ID: 20372830 [TBL] [Abstract][Full Text] [Related]
15. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Kato N; Sasou S; Motoyama T Mod Pathol; 2006 Jan; 19(1):83-9. PubMed ID: 16258507 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma: A Tissue Microarray Study of 130 Cases. Ye S; Yang J; You Y; Cao D; Huang H; Wu M; Chen J; Lang J; Shen K Medicine (Baltimore); 2016 Mar; 95(9):e3003. PubMed ID: 26945423 [TBL] [Abstract][Full Text] [Related]
17. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis. Higashiguchi A; Yamada T; Susumu N; Mori T; Suzuki A; Aoki D; Sakamoto M Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029 [TBL] [Abstract][Full Text] [Related]
18. Hypomethylation of hepatocyte nuclear factor-1beta (HNF-1beta) CpG island in clear cell carcinoma of the ovary. Kato N; Tamura G; Motoyama T Virchows Arch; 2008 Feb; 452(2):175-80. PubMed ID: 18066692 [TBL] [Abstract][Full Text] [Related]
19. Alterations in β-catenin, microsatellite instability, and HNF-1β levels are independently associated with ovarian endometriosis-associated tumorigenesis. Tomohiro M; Matsumoto T; Miura R; Oguri Y; Yokoi A; Tochimoto M; Saegusa M Hum Pathol; 2019 Jul; 89():10-23. PubMed ID: 31022415 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma. Li Q; Zeng X; Cheng X; Zhang J; Ji J; Wang J; Xiong K; Qi Q; Huang W Int J Clin Exp Pathol; 2015; 8(7):8305-10. PubMed ID: 26339401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]